Literature DB >> 7434282

Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.

P L Haslam, C W Turton, A Lukoszek, A J Salsbury, A Dewar, J V Collins, M Turner-Warwick.   

Abstract

Bronchoalveolar lavage was used to sample inflammatory cells from the lungs of 51 patients with cryptogenic fibrosing alveolitis (CFA) (24 smokers, 12 ex-smokers, and 15 non-smokers). The smokers with CFA have been compared with 15 smoking control subjects in whom there was no radiographic abnormality or clinical evidence of chronic bronchitis. Significantly lower volumes of lavage fluid were recovered from the smokers with CFA (p < 0.001) and the fluid contained lower percentages of macrophages (p < 0.01), reflecting increased percentages of eosinophils (p < 0.001) and neutrophils (p < 0.01). Similar changes were seen in the ex-smokers and non-smokers. There was also an increase in the percentages of lymphocytes when the whole group of CFA patients was compared with the control subjects (p less than or equal to 0.05). No significant differences were found when patients with "lone" CFA were compared with those having associated systemic disease. The only feature distinguishing smokers from non-smokers with CFA was the presence of pigmented cytoplasmic inclusions in the macrophages from the smokers (p < 0.001). However, there were lower numbers of pigmented macrophages in the smoking CFA patients by comparison with the control subjects suggesting either a change in phagocytic capacity or turnover rate in this disease. Profiles of differential cell counts in individual patients showed that increases of eosinophils over 3% or neutrophils over 4% or both with lymphocyte counts of less than 11% related to a poor clinical response to corticosteroids, but lymphocyte percentages greater than 11% related to improvement (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7434282      PMCID: PMC471286          DOI: 10.1136/thx.35.5.328

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Immunocompetent cells from the lower respiratory tract of normal human lungs.

Authors:  R P Daniele; M D Altose; D T Rowlands
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

2.  Collagenase production by lymphokine-activated macrophages.

Authors:  L M Wahl; S M Wahl; S E Mergenhagen; G R Martin
Journal:  Science       Date:  1975-01-24       Impact factor: 47.728

3.  Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers.

Authors:  A R Brody; J E Craighead
Journal:  Lab Invest       Date:  1975-02       Impact factor: 5.662

4.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

5.  Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.

Authors:  W König; B M Czarnetzki; L M Lichtenstein
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

6.  Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.

Authors:  H Y Reynolds; H H Newball
Journal:  J Lab Clin Med       Date:  1974-10

7.  The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers.

Authors:  S A Pratt; M H Smith; A J Ladman; T N Finley
Journal:  Lab Invest       Date:  1971-05       Impact factor: 5.662

8.  Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies.

Authors:  M Turner-Warwick; P Haslam; J Weeks
Journal:  Clin Allergy       Date:  1971-06

9.  Effects of granulocyte neutral proteases on complement components.

Authors:  U Johnson; K Ohlsson; I Olsson
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes.

Authors:  T C Kravis; A Ahmed; T E Brown; J D Fulmer; R G Crystal
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  31 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

3.  Pulmonary gamma interferon production in patients with fibrosing alveolitis.

Authors:  B W Robinson; A H Rose
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

Authors:  M Turner-Warwick; W McAllister; R Lawrence; A Britten; P L Haslam
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

5.  Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.

Authors:  J G Hay; P L Haslam; A Dewar; B Addis; M Turner-Warwick; G J Laurent
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

6.  Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.

Authors:  G Nakos; E I Kitsiouli; I Tsangaris; M E Lekka
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

7.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.

Authors:  M A Johnson; S Kwan; N J Snell; A J Nunn; J H Darbyshire; M Turner-Warwick
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

8.  Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis.

Authors:  N Shimizudani; H Murata; H Keino; S Kojo; H Nakamura; Y Morishima; T Sakamoto; M Ohtsuka; K Sekisawa; M Sumida; T Sumida; T Matsuoka
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests.

Authors:  R Bégin; M Rola-Pleszczynski; S Massé; D Nadeau; G Drapeau
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

10.  Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests.

Authors:  A G Davison; P L Haslam; B Corrin; I I Coutts; A Dewar; W D Riding; P R Studdy; A J Newman-Taylor
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.